NENDOCABTAGENE ONOGEDLEUCEL
UNII Q137JC2CLV

Substance Identification & Data

This profile provides standardized clinical and technical data for Nendocabtagene Onogedleucel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q137JC2CLV.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2783320-97-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q137JC2CLV

CAS Registry Number

2783320-97-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NENDOCABTAGENE ONOGEDLEUCEL

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C165779

National Cancer Institute reference terminology for clinical and research data.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

ITIS TSN

180092

Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.

NCBI Taxonomy

9606

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nendocabtagene Onogedleucel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NENDOCABTAGENE ONOGEDLEUCEL

Common Names & Synonyms

ALLO 715 [WHO-DD]

ANTI-BCMA CAR T-CELL THERAPY ALLO715

NENDOCABTAGENE ONOGEDLEUCEL (INN)

NOTES: ALLOGENIC T-CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR DIRECTED TO THE B-CELL MATURATION ANTIGEN (BCMA) FOR ANTICIPATED USE IN TREATING PATIENTS WITH MULTIPLE MYELOMA